GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (XCNQ:MYCO) » Definitions » E10

Mydecine Innovations Group (XCNQ:MYCO) E10 : C$-1,532,520.00 (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mydecine Innovations Group's adjusted earnings per share data for the three months ended in Sep. 2023 was C$-1.570. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-1,532,520.00 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-10), Mydecine Innovations Group's current stock price is C$0.015. Mydecine Innovations Group's E10 for the quarter that ended in Sep. 2023 was C$-1,532,520.00. Mydecine Innovations Group's Shiller PE Ratio of today is .


Mydecine Innovations Group E10 Historical Data

The historical data trend for Mydecine Innovations Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group E10 Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -1,532,520.00

Competitive Comparison of Mydecine Innovations Group's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Shiller PE Ratio falls into.



Mydecine Innovations Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mydecine Innovations Group's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-1.57/125.2304*125.2304
=-1.570

Current CPI (Sep. 2023) = 125.2304.

Mydecine Innovations Group Quarterly Data

per share eps CPI Adj_EPS
201311 0.000 97.182 0.000
201402 0.000 98.051 0.000
201405 -11,250,100.000 99.394 -14,174,399.569
201408 0.000 99.315 0.000
201412 -22.500 98.367 -28.645
201503 -45.001 99.789 -56.474
201506 -90.001 100.500 -112.147
201509 -10.286 100.421 -12.827
201512 -45.001 99.947 -56.385
201603 -6.750 101.054 -8.365
201606 -22.500 102.002 -27.624
201609 -13.500 101.765 -16.613
201612 -202.502 101.449 -249.973
201703 -67.501 102.634 -82.363
201706 -67.501 103.029 -82.047
201709 -6.144 103.345 -7.445
201712 -179.687 103.345 -217.740
201803 -45.455 105.004 -54.211
201806 -112.613 105.557 -133.601
201809 -12.209 105.636 -14.474
201812 -119.500 105.399 -141.985
201903 -10.500 106.979 -12.291
201906 -2.500 107.690 -2.907
201909 -2.000 107.611 -2.327
201912 -27.926 107.769 -32.451
202003 -0.500 107.927 -0.580
202006 -2.500 108.401 -2.888
202009 -4.000 108.164 -4.631
202012 -4.050 108.559 -4.672
202103 -1.290 110.298 -1.465
202106 -1.750 111.720 -1.962
202109 -0.940 112.905 -1.043
202112 -2.230 113.774 -2.455
202203 -1.200 117.646 -1.277
202206 -0.350 120.806 -0.363
202209 -0.040 120.648 -0.042
202212 0.030 120.964 0.031
202303 -0.410 122.702 -0.418
202306 -0.130 124.203 -0.131
202309 -1.570 125.230 -1.570

Add all the adjusted EPS together and divide 10 will get our e10.


Mydecine Innovations Group  (XCNQ:MYCO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mydecine Innovations Group E10 Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (XCNQ:MYCO) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Executives
David Joshua Bartch Director

Mydecine Innovations Group (XCNQ:MYCO) Headlines

No Headlines